Tag Archives: ACE inhibitors
March 2013 Br J Cardiol 2013;20:11–13 doi:10.5837/bjc.2013.005
Underuse of beta blockers in patients with heart failure
Laxman Dubey, Paul Kalra, Henry Purcell
Our letter from Nepal below shows underuse of beta blockers is a widespread problem As outlined in the recent European Society of Cardiology (ESC) guidelines for the treatment of heart failure,1 the pivotal trials with beta blockers were conducted in patients with continuing symptoms and a persistently low ejection fraction (EF), despite treatment with an ACE inhibitor and, in most cases, a diuretic. Despite this, “there is consensus that these treatments are complementary and that a beta blocker and an ACE inhibitor should both be started as soon as possible after diagnosis of heart failure with reduced ejection fraction (HF-REF)”.1
March 2013 Br J Cardiol 2013;20(suppl 1): S1–S16 doi:10.5837/bjc.2013.s01
Optimising hypertension treatment: NICE/BHS guideline implementation and audit for best practice
Dr Terry McCormack, Dr Chris Arden, Dr Alan Begg, Professor Mark Caulfield, Dr Kathryn Griffith, Ms Helen Williams
(more…)
September 2010 Br J Cardiol 2010;17:211-14
News from the 2010 Congress of the European Society of Cardiology
Highlights of this year’s European Society of Cardiology Congress, held in Stockholm, Sweden, from August 28th to September 1st included a new drug which benefits heart failure by slowing heart rate, and more exciting results from oral compounds that could replace warfarin in various indications. Highlights of this year’s European Society of Cardiology Congress, held in Stockholm, Sweden, from August 28th to September 1st included a new drug which benefits heart failure by slowing heart rate, and more exciting results from oral compounds that could replace warfarin in various indications. SHIFT: ivabradine shows benefit in heart failure
January 2005 Br J Cardiol 2005;12:65-70
Evidence-based treatment of hypertension: what’s the role of angiotensin II receptor blockers?
FD Richard Hobbs, Peter Irwin, Janet Rubner
No content available
January 2003 Br J Cardiol 2003;10:36-43
Prescribing of ACE inhibitors and statins after bypass surgery: a missed opportunity for secondary prevention?
R Andrew Archbold, Azfar G Zaman, Nicholas P Curzen, Peter G Mills
No content available
March 2002 Br J Cardiol 2002;9:158-62
The clinical application of ACE inhibitors in coronary artery disease
Abba Gomma, John Henderson, Henry Purcell, Kim Fox
No content available
For healthcare professionals only
